I-PARTS Integrated Platform for Anti-Cancer Radiation Therapeutics Screening. Utilization of Engineered Single cell arrays and traditional Clonogenic assays.

Project: Research project

Project Details

Description

Overall project will develop an engineered cell array to replace standard clonogenic assays. Engineered cell printing will be utilized in order to improve upon standard seeding approaches and cell plating efficiency. This will be coupled with dosimetry and high-throughput in situ irradiation and cell and colony characterization and monitoring. Ultimately a prototype system will incorporate tissue culture incubation system, irradiation system and microscopy. Subcontract will entail testing of the prototype and comparisons against standard clonogenic assays for several cancer cell lines.
StatusFinished
Effective start/end date9/16/199/15/21

Funding

  • PACT & Health LLC (75N91019C00043 // 75N91019C00043)
  • National Cancer Institute (75N91019C00043 // 75N91019C00043)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.